# High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

> **NCT05947071** · PHASE2 · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 312 (estimated)

## Conditions studied

- Immunization; Infection
- Transplantation Infection
- Influenza

## Interventions

- **BIOLOGICAL:** Standard Dose Quadrivalent Inactivated Influenza Vaccine
- **BIOLOGICAL:** High Dose Quadrivalent Inactivated Influenza Vaccine

## Key facts

- **NCT ID:** NCT05947071
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-26
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 312 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05947071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05947071, "High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05947071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*